Skip to main content

Table 2 Clinical and laboratory parameters of P. falciparum malaria patients

From: Liver changes in severe Plasmodium falciparum malaria: histopathology, apoptosis and nuclear factor kappa B expression

 

Non-hyperbilirubinaemia (TB < 51.3 μmol/L) (n = 10)

Hyperbilirubinaemia (TB ≥ 51.3 μmol/L) (n = 12)

Age (years) (p = 0.974)

25.8 ± 3.95

26.17 ± 4.28

Sex (M:F)

6:4

10:2

Days of fever (p = 0.095)

4.1 ± 0.82

5.83 ± 0.77

Parasitaemia (/μl) (p = 0.619)

303,186.67 ± 151,070.30

391,501.40 ± 183,362.30

Albumin (g/L) (p = 0.006)

33.2 ± 0.17

25.3 ± 0.13

AST (U/L) (p = 0.006)

72.00 ± 21.41

266.33 ± 64.93

ALT (U/L) (p = 0.049)

49.17 ± 8.23

126.79 ± 29.22

Alkaline phosphatase (U/L) (p = 0.049)

8.42 ± 2.62

20.07 ± 4.33

Total bilirubin (μmol/L) (p = 0.001)

30.61 ± 0.31

441.60 ± 5.39

Direct bilirubin (μmol/L) (p = 0.001)

8.55 ± 0.15

217.17 ± 2.73